Cargando…

Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance

We analyzed China’s current use of and microbial resistance to antibiotics, and possible means of reducing antimicrobial resistance. Interventions like executive orders within clinical settings and educational approach with vertical approaches rather than an integrated strategy to curb the use of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Dan, Liu, Xinliang, Hawkey, Peter, Li, Hao, Wang, Quan, Mao, Zongfu, Sun, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805194/
https://www.ncbi.nlm.nih.gov/pubmed/29239248
http://dx.doi.org/10.1177/0300060516686230
_version_ 1783298922576347136
author Cui, Dan
Liu, Xinliang
Hawkey, Peter
Li, Hao
Wang, Quan
Mao, Zongfu
Sun, Jing
author_facet Cui, Dan
Liu, Xinliang
Hawkey, Peter
Li, Hao
Wang, Quan
Mao, Zongfu
Sun, Jing
author_sort Cui, Dan
collection PubMed
description We analyzed China’s current use of and microbial resistance to antibiotics, and possible means of reducing antimicrobial resistance. Interventions like executive orders within clinical settings and educational approach with vertical approaches rather than an integrated strategy to curb the use of antimicrobials remain limited. An underlying problem is the system of incentives that has resulted in the intensification of inappropriate use by health professionals and patients. There is an urgent need to explore the relationship between financial and non-financial incentives for providers and patients, to eliminate inappropriate incentives. China’s national health reforms have created an opportunity to contain inappropriate use of antibiotics through more comprehensive and integrated strategies. Containment of microbial resistance may be achieved by strengthening surveillance at national, regional and hospital levels; eliminating detrimental incentives within the health system; and changing prescribing behaviors to a wider health systems approach, to achieve long-term, equitable and sustainable results and coordinate stakeholders’ actions through transparent sharing of information.
format Online
Article
Text
id pubmed-5805194
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-58051942018-02-14 Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance Cui, Dan Liu, Xinliang Hawkey, Peter Li, Hao Wang, Quan Mao, Zongfu Sun, Jing J Int Med Res Special Issue: Healthcare-Associated Infections and Antimicrobial Resistance: Findings and Policy Implications We analyzed China’s current use of and microbial resistance to antibiotics, and possible means of reducing antimicrobial resistance. Interventions like executive orders within clinical settings and educational approach with vertical approaches rather than an integrated strategy to curb the use of antimicrobials remain limited. An underlying problem is the system of incentives that has resulted in the intensification of inappropriate use by health professionals and patients. There is an urgent need to explore the relationship between financial and non-financial incentives for providers and patients, to eliminate inappropriate incentives. China’s national health reforms have created an opportunity to contain inappropriate use of antibiotics through more comprehensive and integrated strategies. Containment of microbial resistance may be achieved by strengthening surveillance at national, regional and hospital levels; eliminating detrimental incentives within the health system; and changing prescribing behaviors to a wider health systems approach, to achieve long-term, equitable and sustainable results and coordinate stakeholders’ actions through transparent sharing of information. SAGE Publications 2017-01-30 2017-12 /pmc/articles/PMC5805194/ /pubmed/29239248 http://dx.doi.org/10.1177/0300060516686230 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Special Issue: Healthcare-Associated Infections and Antimicrobial Resistance: Findings and Policy Implications
Cui, Dan
Liu, Xinliang
Hawkey, Peter
Li, Hao
Wang, Quan
Mao, Zongfu
Sun, Jing
Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance
title Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance
title_full Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance
title_fullStr Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance
title_full_unstemmed Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance
title_short Use of and microbial resistance to antibiotics in China: a path to reducing antimicrobial resistance
title_sort use of and microbial resistance to antibiotics in china: a path to reducing antimicrobial resistance
topic Special Issue: Healthcare-Associated Infections and Antimicrobial Resistance: Findings and Policy Implications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805194/
https://www.ncbi.nlm.nih.gov/pubmed/29239248
http://dx.doi.org/10.1177/0300060516686230
work_keys_str_mv AT cuidan useofandmicrobialresistancetoantibioticsinchinaapathtoreducingantimicrobialresistance
AT liuxinliang useofandmicrobialresistancetoantibioticsinchinaapathtoreducingantimicrobialresistance
AT hawkeypeter useofandmicrobialresistancetoantibioticsinchinaapathtoreducingantimicrobialresistance
AT lihao useofandmicrobialresistancetoantibioticsinchinaapathtoreducingantimicrobialresistance
AT wangquan useofandmicrobialresistancetoantibioticsinchinaapathtoreducingantimicrobialresistance
AT maozongfu useofandmicrobialresistancetoantibioticsinchinaapathtoreducingantimicrobialresistance
AT sunjing useofandmicrobialresistancetoantibioticsinchinaapathtoreducingantimicrobialresistance